We are pleased to announce that Onat Akbulut, has joined MUB Medical Solutions as part of our growing scientific and technical development team.

Onat is currently pursuing his PhD in Cell & Tissue Engineering and holds a degree in Metallurgical and Materials Engineering. His academic work is anchored in Bioengineering and the Cell & Tissue Engineering, where he focuses on the interface between biological tissues and engineered materials.

At MUB, Onat will play a central role in the design and development of pre-clinical studies related to our Sutrips technology. His expertise in tissue healing, material-tissue interaction, and biological response analysis brings important depth to our product development team. He will also contribute to material evaluation and help ensure that our choices align with both clinical performance goals and biological compatibility standards.

With Onat joining forces with Natale Rolim and Sara Zulfiqar, we are building a dedicated and interdisciplinary foundation for moving Sutrips forward through the final stages of product development, pre-clinical validation, and regulatory preparation.

“With Onat on board, we gain not only deep academic expertise but also a scientific mindset that complements our regulatory and clinical development goals. His contribution will be important as we finalize our pre-clinical planning and ensure the biological strength of our technology,” says Yasar Shaikh, CEO of MUB Medical Solutions.

We look forward to the next steps in our journey and are proud to have Onat as part of the team.